Clinical Trials
The Department of Psychiatry & Behavioral Sciences welcomes research participants ages 12 to 70 to enroll in studies aimed at improving the diagnosis and treatment of schizophrenia, bipolar disorder, Alzheimer’s disease, depression and anxiety. Browse the entries below and call the associated telephone numbers to learn how you can volunteer to help advance our understanding of psychiatric illness.
If you have questions, please call the Clinical Research Program office at 312-503-9100.
Feinberg Clinical Trials
Scientists at the medical school are conducting hundreds of clinical trials daily. Learn more about all our work via the Feinberg Office of Research Clinical Trials page. Search for trials by disease or condition.
| Trials |
|---|
Northwestern University The Department of Psychiatry and Behavioral Sciences, Clinical Research Program (NU CRP) Recruitment PipelineThe recruitment pipeline provides research staff with an organized system of identifying researchsubjects.NU CRP clinical research studies covers a wide spectrum of Axis I Diagnoses such as schizophrenia, depression, anxiety, etc. NU CRP also conducts research studies for patients who are diagnosed with certain neurological diseases such as Alzheimer’… The recruitment pipeline provides research staff with an organized system of identifying researchsubjects.NU CRP clinical research studies covers a wide spectrum of Axis I Diagnoses such as schizophrenia, depression, anxiety, etc. NU CRP also conducts research studies for patients who are diagnosed with certain neurological diseases such as Alzheimer’s disease, Tourette’s Syndrome, etc. NU CRP conducts basic, translational and clinical research. Personal Health Information (PHI) will not be collected. All information collected in this recruitmentregistry is based on the patient self-report. You will be contacted to answer additional questions by someone in the study staff and to determine your eligibility for the current studies. |
LiveWell: A Mobile Intervention for Bipolar DisorderThis study is being done to evaluate the use of a mobile phone intervention for bipolar disorder that aims to improve patient self-management and increase the effectiveness of psychological interventions. The goal is to reduce symptoms and prevent relapse in people with bipolar disorder. If you are eligible for … This study is being done to evaluate the use of a mobile phone intervention for bipolar disorder that aims to improve patient self-management and increase the effectiveness of psychological interventions. The goal is to reduce symptoms and prevent relapse in people with bipolar disorder. If you are eligible for the study, your participation will last up to 12 months. Individuals 18-65 years old who have been diagnosed with bipolar disorder and are currently working with a psychiatrist
NCT03088462 STU00202860 |
BP40283 -Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess The Effects of RO6889450 in Patients with Schizophrenia or Schizoaffective Disorder and Negative SymptomsThe purpose of this study is to find out what effects, good or bad, the study medication RO6889450, has on you and symptoms of your schizophrenia or schizoaffective disorder. You were selected as a possible participant in this study because you have been diagnosed with schizophrenia or schizoaffective disorder and … The purpose of this study is to find out what effects, good or bad, the study medication RO6889450, has on you and symptoms of your schizophrenia or schizoaffective disorder.
You were selected as a possible participant in this study because you have been diagnosed with schizophrenia or schizoaffective disorder and negative symptoms (thoughts, feelings, or behaviors normally present that are absent or diminished in people with schizophrenia or schizoaffective disorder)
This study is intended to contribute to the further development of the study medication. The study medication is still being tested and has not been approved by any national health authority, including the US Food and Drug Administration (FDA). You have been diagnosed with schizophrenia or schizoaffective disorder and negative symptoms(thoughts, feelings, or behaviors normally present that are absent or diminished in people with schizophrenia or schizoaffective disorder)
NCT03669640 STU00209192 |
A Randomized, Double-Blind Controlled Comparison of NRX-101 to Standard of Care for Patients with Bipolar Depression and Subacute Suicidal Ideation and BehaviorDo you or anyone you know have bipolar depression and struggling with suicidal thoughts and/or actions?This study will assess the ability of a new combination of investigational medications to decrease your symptoms of depression, reduce your suicidal thoughts and maintain stability. Study participation will be up to 7 … Do you or anyone you know have bipolar depression and struggling with suicidal thoughts and/or actions? This study will assess the ability of a new combination of investigational medications to decrease your symptoms of depression, reduce your suicidal thoughts and maintain stability.
Study participation will be up to 7 visits for 10 weeks.
You will be compensated for your time. You may be eligible for this study if you meet the following criteria:
· Ages 18-65 · Diagnosed with Bipolar Depression · Currently having suicidal thoughts · Understand and sign an informed consent document
NCT03395392 STU00217372 |